Decrease in toll-like receptors 2 and 4 in the spleen of mouse with endotoxic tolerance

Inflammation Research

Volumn 57, Issue 6, 2008, Pages 252-259

  Zhong, B ^a,b   Ma, H Ying ^b   Yang, Q ^b   Gu, F Rong ^c   Yin, G Qing ^b   Xia, C Ming ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Endotoxin tolerance; Lipopolysaccharide; TLR2; TLR4; Toll like receptor

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SEPTIC SHOCK; SPLEEN; WESTERN BLOTTING;

ANIMALS; ENDOTOXINS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 46449132224     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7104-4     Document Type: Article

References (59)

1. Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006; 12: 133-50.
2. Ertel W, Kremer J P, Kenney J, Steckholzer U, Jarrar D, Trentz O et al. Downregulation of proinflammatory cytokine release inwhole blood from septic patients. Blood 1995; 85: 1341-7.
3. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
4. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-25.
5. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll like receptor 2. J Biol Chem 1999; 274: 17406-9.
6. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419-25.
7. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC et al. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 2002; 168: 5252-9.
8. Fan H, Cook JA. Molecular mechanisms of endotoxic tolerance. J Endotoxin Res 2004; 10: 71-84.
9. Boujoukos AJ, Martich GD, Supinski E, Suffredini AF. Compart- mentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol 1993; 74: 3027-33.
10. van Deventer SJ, Hart M, van der Poll T, Hack CE, Aarden LA. Endotoxin and tumor necrosis factor-alpha induced interleukin-8 release in humans. J Infect 1993; 167: 461-4.
11. Pernerstorfer T, Schmid R, Bieglmayer C, Eichler HG, Kapiotis S, Jilma B. Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther 1999; 66: 51-7.
12. Redl H, Bahrami S, Schlag G, Traber DL. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993; 187: 330-45.
13. Premaratne S, May ML, Nakasone CK, McNamara JJ. Pharmacokinetics of endotoxin in rhesus macaque septic shock model. J Surg Res 1995; 59: 428-32.
14. Yin GQ, Qiu HB, Du KH, Tang JQ, Lu CP, Fang ZX. Endotoxic shock model with fluid resuscitation in Macaca mulatto. Lab Anim 2005; 39: 269-79.
15. Yin GQ, Ji XH, Gu FR, Lu CP, Fang ZX, Zhao W et al. Effect of fluid resuscitation on ryanodine receptor in macaques with endotoxic shock. Resuscitation 2006; 70: 145-52.
16. Hajek M, Trcka V, Vanecek M, Helfert I, Misak J. A model of experimental endotoxin shock in monkeys and its therapeutic control. Z Exp Chir 1978; 11: 317-21.
17. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. Endotoxic tolerance: is there a clinical relevance. J Endotoxin Res 2003; 9; 101-7.
18. Yin GQ, Qiu HB, Du KH, Tang JQ, Lu CP, Fang ZX. Endotoxic shock model with fluid resuscitation in Macaca mulatto, author reply. Lab Anim 2006; 40: 104-6.
19. Alves-Rosa F, Vulcano M, Beigier-Bompadre M, Fernandez G, Palermo M, Isturiz MA. Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice. Clin Exp Immunol 2002; 128: 221-8.
20. Li CH, Wang JH, Redmond HP. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation. J Leukoc Biol 2006; 79: 867-75.
21. Siedlar M, Frankenberger M, Benkhart E, Espevik T, Quirling M, Brand K et al. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J Immunol 2004; 173: 2736-45.
22. Monari C, Bistoni F, Casadevall A, Pericolini E, Pietrella D, Kozel TR et al. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J Infect Dis. 2005; 191: 127-37.
23. Na YJ, Han SB, Kang JS, Yoon YD, Park SK, Kim HM et al. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int Immunopharmacol 2004; 4: 1187-99.
24. LaRue KE, McCal CE. A labile transcriptional repressor modulates endotoxic tolerance. J Exp Med 1994; 180: 2269-75.
25. Chan C, Li L, McCAll CE, Yoza BK. Endotoxic tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J Immunol 2005; 175: 461-8.
26. Lehner MD, Ittner J, Bundschuh DS, van Rooijen N, Wendel A, Hartung T. Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun 2001; 69: 463-71.
27. Akira S, Sato S. Toll-like receptors and their signaling mechanisms. Scand J Infect. Dis 2003; 35: 555-62.
28. Akira S, Takeda K. Functions of Toll-like receptors: lessons from KO mice. C R Biol 2004; 327: 581-9.
29. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M et al. Cutting edge: endotoxic tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000; 164: 3476-9.
30. Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 2002; 169: 5209-16.
31. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxic tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001; 167: 5278-85.
32. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002; 99: 3427-31.
33. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol 2002; 168: 554-61.
34. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999; 104: 271-80.
35. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001; 166: 2018-24.
36. Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998-6004.
37. Matsumura T, Ito A, Takii T, Hayashi H, Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 2000; 20: 915-21.
38. Medvedev AE, Kopydlowski KM, Vogel SN. Inhibition of lipopolysaccharide- induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000; 164: 5564-74.
39. Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 2000; 165: 5767-72.
40. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 2002; 168: 1286-93.
41. Xiong J, Zhu ZH, Liu JS, Wang Y, Wu HS. The expression of toll-like receptor 2, 4 of livers in mice with systemic inflammatory response syndrome. Hepatobiliary Pancreat Dis Int 2006; 5: 143-6.
42. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002; 195: 559-70.
43. Deiters U, Gumenscheimer M, Galanos C, Muhlradt PF. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses. Infect Immun 2003; 71: 4456-62.
44. Sumikawa Y, Asada H, Hoshino K, Azukizawa H, Katayama I, Akira S et al. Induction of beta-defensin 3 in keratinocytes stimulated by bacterial lipopeptides through toll-like receptor 2. Microbes Infect 2006; 8: 1513-21.
45. Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B et al. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 2001; 69: 474-81.
46. Beeson PB. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc Soc Exp Biol Med 1946; 61: 248-50.
47. Freeman HH. Passive transfer of tolerance to pyrogenicity of bacterial endotoxin. J Exp Med 1960; 111: 453-63.
48. Greisman SE, Hornick RB, Wagner Jr HN, Woodward WE, Woodward TE. The role of endotoxin during typhoid fever and tularemia in man. IV. The integrity of the endotoxic tolerance mechanisms during infection. J Clin Invest 1969; 48: 613-29.
49. Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JPG, Smeets MB et al. In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions. Circulation 2002; 106: 1985-90.
50. Dias MB, Almeida MC, Carnio EC, Branco LG. Role of nitric oxide in tolerance to lipopolysaccharide in mice. J Appl Physiol 2005; 98: 1322-7.
51. Hirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada M et al. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005; 90: 548-56.
52. Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A et al. Inhibition of TLR4/MD2 signaling by RP105/MD-1. J Endotoxin Res 2005; 11: 363-8.
53. Heemann U, Szabo A, Hamar P, Muller V, Witzke O, Lutz J et al. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am J Pathol 2000; 156: 287-93.
54. McCabe WR. Endotoxin tolerance. I. Its induction by experimental pyelonephritis. J Clin Invest 1963; 42: 610-7.
55. McCabe WR. Endotoxin tolerance. II. Its occurrence in patients with pyelonephritis. J Clin Invest 1963; 42: 618-25.
56. He W, Fong Y, Marano MA, Gershenwald JE, Yurt RW, Moldawer LL et al. Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J Infect Dis 1992; 165: 859-64.
57. Lorenz E. TLR2 and TLR4 expression during bacterial infections. Curr Pharm Des 2006; 12: 4185-93.
58. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003; 112: 1234-43.
59. Lorenz E, Chemotti DC, Jiang AL, McDougal LD. Differential involvement of toll-like receptors 2 and 4 in the host response to acute respiratory infections with wild-type and mutant Haemophilus influenzae strains. Infect Immun 2005; 73: 2075-82.